Bristol-Myers Squibb Co (OTCPK:BMYMP.PFD) Stock News, Headlines & Updates
Bristol-Myers Squibb Co Stock News from GuruFocus
- 1
- 2
- 3
Jul 21, 2025
Bristol Myers Squibb (BMY) Awaits FDA Review for Psoriatic Arthritis Treatment
GuruFocus News • 8:58am
FDA Reviews Bristol Myers' sNDA for Sotyktu in Psoriatic Arthritis | BMY Stock News
GuruFocus News • 6:17am
Bristol Myers Squibb's Supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Accepted for Review Across Four Regions Global
GuruFocus News • 6:15am
Jul 18, 2025
Bristol Myers Squibb (BMY) Reports Reblozyl Phase 3 Trial Outcome
GuruFocus News • 6:57am
BMY: Bristol Myers Shares Update on Reblozyl's Phase 3 Trial | BMY Stock News
GuruFocus News • 6:17am
Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia | BMY Stock News
GuruFocus News • 6:15am
Bristol-Myers Squibb Co (BMY) Announces Phase 3 Trial Results for Reblozyl | BMY stock news
GuruFocus News • 6:02am
Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia
Business Wire • 6:00am
Jul 17, 2025
Bristol-Myers Squibb (BMY) and Pfizer Announce Eliquis Discount Program
GuruFocus News • 6:58am
BMY Initiates Direct-to-Patient Discount Plan for Eliquis | BMY Stock News
GuruFocus News • 6:17am
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option | BMY Stock News
GuruFocus News • 6:16am
Bristol-Myers Squibb Co (BMY) Launches Direct-to-Patient Option for Eliquis | BMY stock news
GuruFocus News • 6:02am
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
Business Wire • 6:00am
Jul 16, 2025
Bristol Myers (BMY) Awaits Phase 3 Results for New Cobenfy Use | BMY Stock News
GuruFocus News • 3:30pm
Jul 14, 2025
Bristol-Myers Squibb Co (BMY) Supports Winn CIPP's Fourth Cohort of Medical Students | BMY stock news
GuruFocus News • 12:02pm
Winn CIPP Welcomes Cohort 4 Medical Students Focused on Connecting Communities to Clinical Research
ACCESSWIRE • 11:00am
Jul 11, 2025
Bristol-Myers Squibb Co (BMY) Shares Down 3.19% on Jul 11
GuruFocus News • 12:03pm
Jul 10, 2025
Morgan Stanley Maintains 'Underweight' Rating for BMY, Lowers Price Target | BMY Stock News
GuruFocus News • 11:34am
Bristol Myers (BMY) Stock Target Reduced by Morgan Stanley | BMY Stock News
GuruFocus News • 8:02am
Jul 01, 2025
Bristol-Myers Squibb Co (BMY) Trading 3.02% Higher on Jul 1
GuruFocus News • 12:04pm
Jun 30, 2025
Bristol-Myers Squibb (BMY) Upgraded to Buy Amid Strategic Partnerships
GuruFocus News • 1:55pm
Jun 27, 2025
Bristol Myers (BMY) Gains FDA Approval for Label Changes on Cancer Therapies
GuruFocus News • 8:57am
Bristol Myers (BMY) Receives FDA Approval for Updated CAR T Cell Therapy Labels | BMY Stock News
GuruFocus News • 4:30am
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels
Business Wire • 10:00pm
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels | BMY Stock News
GuruFocus News • 9:15pm
Jun 24, 2025
Bristol Myers Squibb (BMY) Faces Antitrust Suit Over Pomalyst Monopoly
GuruFocus News • 1:57pm
Jun 23, 2025
Bristol-Myers Squibb (BMY) Gains FDA Orphan Drug Status for Sickle Cell Treatment | BMY Stock News
GuruFocus News • 2:45pm
Jun 18, 2025
Bristol Myers Squibb (BMY) Collaborates on Alzheimer's Drug Development | BMY Stock News
GuruFocus News • 3:30pm
Bristol Myers Squibb (BMY) Loses Key Executive to Climb Bio | BMY Stock News
GuruFocus News • 6:31am
Jun 17, 2025
Bristol-Myers Squibb Co (BMY) Announces Quarterly Dividends for Common and Preferred Stock | BMY stock news
GuruFocus News • 4:11pm
Bristol Myers Squibb Announces Dividend
Business Wire • 4:00pm
Bristol Myers Squibb Announces Dividend | BMY Stock News
GuruFocus News • 3:30pm
Jun 16, 2025
Bristol Myers Squibb (BMY) Achieves Strong Results with Breyanzi in Lymphoma Study
GuruFocus News • 8:56am
Bristol Myers (BMY) Reports Promising Results from Lymphoma Study | BMY Stock News
GuruFocus News • 6:17am
Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel) | BMY Stock
GuruFocus News • 6:15am
Bristol-Myers Squibb Co (BMY) Unveils Promising Results for Breyanzi in Marginal Zone Lymphoma Study | BMY stock news
GuruFocus News • 6:03am
Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel)
Business Wire • 6:00am
Jun 12, 2025
Bristol Myers (BMY) Showcases Promising New Data on Targeted Protein Degradation | BMY Stock News
GuruFocus News • 6:31am
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news